
Potential Savings in the Second Year of the IRA Prescription Drug Negotiation Program.
The IRA Prescription Drug Negotiation Program generated estimated savings of $12 billion in Medicare costs for 15 medications. The Maximum Fair Prices (MFP) applied for 2024 showed expected savings of $12.5 billion, with prices 44% lower than pre-IRA prices. The largest savings come from medications with fewer prior discounts.
